Business Strategies - Page 5 of 7 - Express Pharma

Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO

Piramal divests its DRG Business for $950 million

Hilleman Laboratories to develop a novel vaccine against Group B Streptococcus

E-pharmacies – what lies ahead?

Rare Diseases: Awaiting renewed focus

Novartis, Merck and Allergan join those raising US drug prices for 2020

Nutraceuticals is the fastest growing segment of biopharmaceutical industry in India

Govt working on strategy on import regulation of non-essential items

2020: Indian pharma ‘sunrise’ segment, prognosis positive for healthcare sector

SCHOTT Glass strenghtens India facility as Asian hub